TrimRX
US$ 23.59
tirzepatide bioavailability Everyone's picking a side. πππ Let the Phase III data settle it. vs SEMAGLUTIDE The most important head-to-head in metabolic medicine right now. Swipe through all 9 slides π βββββββββββββββββββββ π¬ The promise of tirzepatide: A
Description
Watch Trimix Injection Instructions Womens Health What is vein therapy
In this small trial, 71 patients with biopsyproven compensated cirrhosis and BMI 27 kg/m 2 (75% with T2D, mean BMI 34.9 kg/m 2 ) were randomised to semaglutide 2.4 mg once weekly ( n = 47) or placebo ( n = 24) for 48 weeks
It is administered as a once weekly subcutaneous injection, or as a daily oral prescription
The primary outcome was percentage change in body weight from drug initiation to 1 year
